Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024

Views
Effectiveness ...17

Total Visits Per Month

September 2025October 2025November 2025December 2025January 2026February 2026March 2026
Effectiveness ...00000017

File Visits

Views
Influenza Resp Viruses - 2024 - Merdrignac - Effectiveness of XBB 1 5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in.pdf7